IRIS PubliCatt

Barone, Carlo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.894
NA - Nord America 2.228
AS - Asia 499
AF - Africa 23
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 5.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.218
DE - Germania 1.393
SE - Svezia 423
CN - Cina 344
IT - Italia 233
PL - Polonia 221
UA - Ucraina 177
GB - Regno Unito 115
IE - Irlanda 100
FR - Francia 79
IN - India 59
FI - Finlandia 55
BE - Belgio 29
TR - Turchia 29
CI - Costa d'Avorio 20
IR - Iran 20
NL - Olanda 16
RU - Federazione Russa 16
VN - Vietnam 16
RO - Romania 11
JP - Giappone 9
HK - Hong Kong 8
BR - Brasile 6
AU - Australia 5
CA - Canada 5
KR - Corea 5
MX - Messico 5
RS - Serbia 5
AE - Emirati Arabi Uniti 3
AT - Austria 3
CH - Svizzera 3
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
ES - Italia 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PK - Pakistan 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
LV - Lettonia 1
MK - Macedonia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.662
Salva come PNG Salva come JPEG
Città #
Chandler 476
Warsaw 206
Ashburn 147
Ann Arbor 123
Jacksonville 114
Dublin 98
San Mateo 97
Nürnberg 89
Nanjing 85
Wilmington 84
Cattolica 82
Dearborn 54
New York 54
Boston 51
Fairfield 42
Houston 40
Woodbridge 40
Nanchang 36
Lawrence 34
Chicago 33
Hangzhou 33
Redmond 33
Redwood City 31
Brussels 29
Beijing 27
Izmir 27
Marseille 27
Princeton 25
Seattle 25
Milan 22
Abidjan 20
Falls Church 20
Mountain View 20
Rome 18
Shanghai 18
Cambridge 17
Hebei 17
Munich 17
Boardman 14
Bremen 14
Leawood 14
Shenyang 14
Can Tho 13
Kraków 13
Norwalk 13
Guangzhou 12
Fremont 11
Kunming 11
Augusta 10
Changsha 10
Helsinki 10
Lancaster 10
Los Angeles 10
San Francisco 10
University Park 10
Detroit 9
London 9
Jiaxing 8
Simi Valley 8
Zhengzhou 8
Andover 7
Hong Kong 7
Jinan 7
Kish 7
Tianjin 7
Changchun 6
Costa Mesa 6
Mannheim 6
Belgrade 5
Lanzhou 5
San Diego 5
Amsterdam 4
Cuauhtémoc 4
Hefei 4
Seoul 4
Tokyo 4
Washington 4
Al Ain City 3
Berlin 3
Clearwater 3
Dong Ket 3
Indiana 3
Millbury 3
Mumbai 3
Ningbo 3
Northbrook 3
Rio De Janeiro 3
Tong 3
Vancouver 3
Xian 3
Zurich 3
Buffalo 2
Chisinau 2
Dallas 2
Gunzenhausen 2
Krakow 2
Las Vegas 2
Legnano 2
Melbourne 2
Naples 2
Totale 2.804
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 334
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 306
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 241
KRAS Early Testing: Consensus Iniziative and Cost-Effectiveness Evaluation for metastatic colerectal patiens in an Italian Setting 214
A phase II study of sunitinib in advanced hepatocellular carcinoma 200
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 190
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 180
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 176
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 152
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 139
Treatment options of simple bone cysts: the role of bone substitutes, growth factors and literature review 126
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 123
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 122
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 120
Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer 115
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 111
AMAROS Study: Overall Survival in Breast Cancer Subtypes 102
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 101
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 100
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 99
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 98
Are TKIs favourable for the elderly with non-small-cell lung cancer? 96
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 93
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 89
Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies 87
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 87
The immune response to tumors as a tool toward immunotherapy 84
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 81
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 79
Advanced colon cancer: staging and prognosis by CEA test 77
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 76
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 74
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 73
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 71
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 71
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 70
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 65
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 64
LUX-Lung 7: is there enough data for a final conclusion? 61
Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series 61
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 60
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 58
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 57
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 56
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 55
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 53
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 53
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 52
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 48
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study 46
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 45
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 39
Randomised, placebo-controlled, double-blind, parallele-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer 38
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations 37
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score 37
Multidisciplinary approach for HCC patients: hepatology for the oncologists 36
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 36
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 36
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis 35
New life for retrospective study in the precision oncology era 27
Targeted therapy in advanced gastric carcinoma: The future is beginning 22
Soft tissue metastases in lung cancer: a review of the literature 12
Totale 5.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 0 0 0 0 0 0 0 0 77 48
2019/2020942 153 64 42 47 83 83 118 43 42 65 130 72
2020/2021581 27 76 46 40 86 33 69 14 76 28 69 17
2021/2022704 54 44 19 79 49 29 16 108 37 49 80 140
2022/20231.267 182 179 106 226 54 158 64 103 118 25 41 11
2023/2024417 24 162 21 18 15 82 33 42 5 15 0 0
Totale 5.746